PERSONAL INFORMATION
Name: Wu Jingxian
Gender: Female
Title: Associate professor
Position: Vice director of Department of Pathology
CONTACT INFORMATION
Email: wujingxian@cqmu.edu.cn
Address: No. 1, Medical School Road, Yuzhong District
Phone: +86- 18623312828
EDUCATION EXPERIENCE
1998.09-2003.06 Chongqing Medical University Clinical Medicine (Bachelor)
2006.09-2009.06 Chongqing Medical University Basic Medicine (Master)
2011.09-2014.06 Chongqing Medical University Tissue engineering and cell engineering (Doctor)
WORKING EXPERIENCE
2003.09-2008.9 Chongqing Medical University teaching assistant Lecture
2008.9-2015.8 Chongqing Medical University Lecture
2015.10-2016.9 Hopkins University Young visiting scholar
2015.9-now Chongqing Medical University Associate professor
RESEARCH INTERESTS
Tumor pathology of center nervous system and female reproductive system
Focus on the mechanism of cerebrovascular disease, and to find differential genes to interfere with neurons and reduce neuronal injury.
HONOUR & AWARDS
1. The third Prize of Chongqing Natural Science Award in 2019, the main completed person (ranked fourth)
2. Excellent resident training tutor of Chongqing Medical University, 2020
FOUNDATIONS
1. Chongqing Talent Plan "Contract System Project", lncRNA AABR070028917.1 as ceRNA-mediated miR-423-5p regulates NLRP3 in cerebral ischemia-reperfusion inflammative injury, 2022/1-2024/12,Host.
2. Chongqing Advanced and applied basic research project and Technology Commission, The mechanism of Sestrin2 against cerebral ischemia-reperfusion oxidative stress injury through AMPK,2015/8-2018/12,Host.
PUBLICATIONS
1. Yueting Wang, Changchang Meng, Jinyan Zhang, Jingxian Wu（co-corresponding author）,Jing Zhao. Inhibition of GSK-3β alleviates cerebral ischemia/reperfusion injury in rats by suppressing NLRP3 inflammasome activation through autophagy. International Immunopharmacology. 2019(68):234-241
2. Zhang Jinyan, Jiang Ning, Zhang Luyu, Zhao Jing*, Jingxian Wu*. NLRP6 expressed in astrocytes aggravates neurons injury after OGD/R through activating the inflammasome and inducing pyroptosis.[J] .Int. Immunopharmacol., 2020, 80: 106183.
3. Siling Ren#,Jingxian Wu# ,Wanchun Yin, Qianqian Liao, Sailan Gong, Beibei Xuan, Xiaoling Mu*. Researches on the Correlation Between Estrogen and Progesterone Receptors Expression and Disease-Free Survival of Endometrial Cancer. Cancer Manag Res 2020;12: 12635–12647
4. Meng C#, Chen S#, He Q, Tan J, Wu J*, Zhao J*. IKZF3 modulates cerebral ischemia/reperfusion injury by inhibiting neuroinflammation. International Immunopharmacology 2023;114（2023）10948
5. Wei Wei, Bo Ye 1, Zhenting Huan, Xiaoling Mu, Jing Qiao, Peng Zhao, Yuehang Jiang, Jingxian Wu*, Xiaohui Zhan. Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer. Cancers (Basel). 2023 Jul 19;15(14)
